Phoenix Review Canada 2026: Men's GLP-1 Weight Loss Clinic
Phoenix is Canada's leading men-only online health clinic, operated by Phoenix Digital Health Inc. - the same company behind Raven for women. With a free assessment, no consultation fees, Ozempic from $299 with a discount, four brand-name GLP-1 options, and a 4.6/5 Trustpilot rating from 879 reviews, Phoenix holds the strongest patient satisfaction score in the Canadian GLP-1 telehealth market. This review covers pricing, province coverage, the clinical process, and how Phoenix compares to Felix, MyRocky, Maple, and Hims.
WeightLossInjections.ca Rating
Non-partner reviewQuick Verdict
Phoenix is the strongest choice for Canadian men who want a free assessment, no recurring consultation fees, brand-name GLP-1 options from four different medications, and the highest independently verified Trustpilot rating in the Canadian telehealth GLP-1 market (4.6/5 from 879 verified reviews). The trade-offs are real: Phoenix is men-only, does not serve PEI or the territories, does not offer generic semaglutide, and does not provide direct insurance billing. For men in the nine provinces served, it is the most cost-transparent and patient-validated option available.
This review is based on publicly available information from the Phoenix platform, Phoenix Digital Health Inc. corporate disclosures, Health Canada drug listings, Trustpilot review data, and pricing comparisons as of June 2026. Phoenix is not an affiliate partner of WeightLossInjections.ca; this review carries no commercial relationship.
What Is Phoenix?
Phoenix is a 100% online men's health clinic operated by Phoenix Digital Health Inc., a Canadian digital health company headquartered in Toronto. The clinic covers multiple men's health categories - weight management, hair loss, sexual health, and other conditions - but has expanded significantly into the GLP-1 weight loss category as demand for telehealth semaglutide and tirzepatide access has grown across Canada.
Phoenix Digital Health Inc. also operates Raven, a parallel platform for women covering equivalent health categories. The two platforms share clinical and technology infrastructure while maintaining separate brand identities and patient populations. For women seeking equivalent services to Phoenix, Raven is the sister offering.
The "men-only" positioning is not marketing exclusivity for its own sake. Phoenix's clinical protocols, physician training, and support content are specifically calibrated for male patients - weight distribution patterns, testosterone interactions with GLP-1 medications, cardiovascular comorbidities common in men, and the specific psychological and social barriers that reduce men's healthcare utilization. Several competing platforms are gender-neutral with no specialized male-health programming, which dilutes the clinical specificity Phoenix offers to male patients.
No referral from a family doctor is required to use Phoenix. The entire process - assessment, prescription, delivery, and follow-up - is conducted online. Patients in any of the nine supported provinces can begin an assessment at any time without prior physician involvement.
How Phoenix Works: Step by Step
Phoenix uses a text-based, asynchronous clinical model. There are no video calls, no phone consultations, and no in-person appointments at any stage of the process. The platform is designed to be completed entirely through the Phoenix web interface or mobile app.
Free online assessment (approximately 10 minutes)
The intake questionnaire covers your health history, weight history, current medications, and treatment goals. Phoenix does not charge for the assessment. The form takes approximately 10 minutes for most patients. No referral or existing bloodwork is required at this stage.
Licensed provider review within 24 hours
A licensed Canadian healthcare provider reviews your assessment asynchronously and makes a prescribing decision. The review is completed through Phoenix's platform - you do not need to be available at a specific time. If the provider has questions, they will contact you via the messaging interface. Approval or denial decisions are typically communicated within 24 hours.
Prescription written and medication shipped (2-3 day delivery)
Approved patients receive their prescription and medication ships within the same business day. Phoenix offers free discreet delivery with 2-3 day shipping across its nine served provinces. Packaging is plain and does not identify the contents or sender. Tracking is provided.
Unlimited text-based follow-up at no extra charge
After your initial prescription, Phoenix provides unlimited text-based follow-up consultations with licensed providers at no additional cost. There are no per-visit charges for ongoing support, dose titration questions, or side effect management. This is the same model used by Felix Health and MyRocky, and it stands in contrast to per-visit models like Maple or DooU.
Phoenix Pricing and Fees
Phoenix's pricing model is one of its most distinctive attributes: the assessment is free and the consultation is free. Patients pay only for their medication. Ongoing follow-up support is included at no additional charge. This flat, medication-only structure makes Phoenix's 12-month cost easier to calculate upfront than layered-fee competitors like DooU or per-visit models like Maple.
| Item | Cost | Notes |
|---|---|---|
| Assessment | Free | No charge to complete the intake questionnaire |
| Initial consultation | Free | Licensed provider review included |
| Follow-up consultations | Free (unlimited) | Text-based; no per-visit charge |
| Delivery | Free | Discreet, tracked, 2-3 day shipping |
| Ozempic (list price) | $375/pen | Brand-name semaglutide weekly injection |
| Ozempic (with 20% discount) | $299/pen | Promotional pricing; confirm current availability at checkout |
| Wegovy | Varies by dose | Higher-dose semaglutide; contact Phoenix for current pricing |
| Mounjaro (tirzepatide) | Varies by dose | Weekly injectable; contact Phoenix for current pricing |
| Zepbound (tirzepatide) | Varies by dose | Tirzepatide; marketed for weight management |
The Ozempic discount pricing ($299 with a 20% promotional discount versus $375 list price) is one of Phoenix's headline competitive positions. This brings brand-name Ozempic to its lowest widely available price point among Canadian GLP-1 telehealth platforms. Patients should confirm promotional pricing at checkout as availability may vary.
Phoenix does not offer generic semaglutide (the Apotex generic launched in May 2026). For patients where generic semaglutide is clinically appropriate and cost is the primary concern, Felix Health and MyRocky both offer the generic from approximately $149/month - substantially less than Phoenix's brand-name pricing even at the discounted rate.
Phoenix also does not provide direct insurance billing. Patients whose benefit plans cover GLP-1 medications will need to submit receipts themselves through their benefits portal for potential reimbursement.
Cost Comparison vs Competitors
The table below compares 12-month all-in cost estimates for a male patient using brand-name Ozempic (approximately $299-375/month through Phoenix, or ~$220-250/month at starting doses through other platforms) with standard included clinical support. Figures are estimates as of June 2026.
| Provider | Consult Fee | Ozempic / Month | 12-Month Est. | Men-Specific? |
|---|---|---|---|---|
| Phoenix | Free | $299 (discounted) | ~$3,588+ | Yes |
| Felix Health | $99 one-time | ~$220-250 | ~$2,739 | No |
| MyRocky | $99 one-time | ~$220-250 | ~$2,739 | No |
| Maple | $69-99 per visit | ~$220-250 | ~$3,000+ | No |
| Hims Canada | Varies | Varies | Not disclosed upfront | No |
The 12-month cost estimate for Phoenix reflects brand-name Ozempic at the discounted $299/month rate. Generic semaglutide-based competitors (Felix Health, MyRocky) come in significantly lower at approximately $2,739 annually. Phoenix is not the least expensive option for Canadian men; it is the most patient-validated option, with the highest Trustpilot rating and the clearest fee structure in the market.
Medications Available Through Phoenix
Phoenix prescribes four brand-name GLP-1 medications - the broadest selection of any Canadian men's health telehealth platform. All four are injectable and weekly-dosed. Phoenix does not offer oral GLP-1 options (Rybelsus) and does not prescribe generic semaglutide.
| Medication | Active Ingredient | Dose Range | Mechanism |
|---|---|---|---|
| Ozempic | Semaglutide | 0.25 mg - 2.0 mg weekly | GLP-1 receptor agonist |
| Wegovy | Semaglutide | 0.25 mg - 2.4 mg weekly | GLP-1 receptor agonist (higher dose) |
| Mounjaro | Tirzepatide | 2.5 mg - 15 mg weekly | Dual GLP-1 + GIP receptor agonist |
| Zepbound | Tirzepatide | 2.5 mg - 15 mg weekly | Dual GLP-1 + GIP receptor agonist |
The inclusion of both Mounjaro and Zepbound (which share the same active ingredient, tirzepatide, but differ in branding and approved indications) gives Phoenix the most comprehensive tirzepatide coverage of any Canadian telehealth platform. Tirzepatide targets both GLP-1 and GIP receptors, producing mean weight loss outcomes in clinical trials that are significantly higher than semaglutide-only agents. For male patients with higher starting body weight or those who have not responded adequately to semaglutide, tirzepatide is a clinically relevant option.
Province Coverage
Phoenix operates in nine Canadian provinces. PEI is the only province in the standard ten-province coverage map where Phoenix does not currently operate. The three federal territories are also not served. Quebec is included in Phoenix's coverage, which distinguishes it from Felix Health and places it alongside MyRocky and DooU as one of the few telehealth platforms offering GLP-1 access to Quebec residents.
| Province / Territory | Phoenix | Felix Health | MyRocky |
|---|---|---|---|
| Ontario | Yes | Yes | Yes |
| British Columbia | Yes | Yes | Yes |
| Alberta | Yes | Yes | Yes |
| Manitoba | Yes | Yes | Yes |
| Saskatchewan | Yes | Yes | Yes |
| Quebec | Yes | No | Yes |
| Nova Scotia | Yes | Yes | Yes |
| New Brunswick | Yes | No | Yes |
| Newfoundland & Labrador | Yes | Yes | Yes |
| PEI | No | Yes | Yes |
| NWT / Nunavut / Yukon | No | No | No |
Weight Loss Timeline on GLP-1 Therapy
GLP-1 medications work through appetite suppression and slowing gastric emptying rather than stimulant-based mechanisms. Results build progressively as doses are titrated upward over a standard escalation protocol. The timeline below reflects clinical trial averages and real-world patient outcomes for male patients on semaglutide or tirzepatide.
| Period | Typical Outcome | What to Expect |
|---|---|---|
| Week 1-4 | Reduced appetite, 1-3 kg loss | Starting dose (0.25 mg semaglutide or 2.5 mg tirzepatide). Gastrointestinal side effects most common in this phase - nausea, constipation. |
| Month 2-3 | 2-5% body weight reduction | First dose titration. Appetite suppression more consistent. Most patients report reduced cravings and smaller portion satisfaction. |
| Month 4-6 | 5-10% body weight reduction | Approaching or reaching maintenance dose. Weight loss rate typically peaks here in response to dose changes. |
| Month 6-12 | 10-15%+ body weight reduction | Continued weight loss at maintenance dose. SCALE trial data: semaglutide at 2.4 mg produced mean 14.9% reduction at 68 weeks. |
| Month 12+ | Plateau and maintenance | Most patients reach a new weight set-point. Discontinuation without lifestyle changes results in weight regain in most cases. Long-term prescribing becoming more common. |
These outcomes represent population averages from controlled clinical trials. Individual results vary based on starting weight, adherence, diet, physical activity, and underlying metabolic conditions. Men's bodies generally respond to GLP-1 medications with similar weight loss trajectories to women, though baseline muscle mass differences may influence body composition outcomes. Phoenix's men-specific clinical protocols are designed to account for these differences in follow-up guidance.
Patient Reviews and Trustpilot Rating
Phoenix holds a 4.6/5 Trustpilot rating from 879 verified patient reviews as of June 2026. This is the highest independently verified Trustpilot rating among Canadian GLP-1 telehealth platforms with a meaningful review volume. For comparison: DooU holds 4.0/5, and several other platforms have either lower scores or insufficient review counts to draw conclusions.
The 879-review sample size is large enough to be statistically meaningful while remaining coherent - most reviews are from genuine patients describing real treatment experiences rather than aggregate institutional validation metrics. This makes Phoenix's Trustpilot profile one of the more useful signals for prospective patients evaluating clinical quality and service reliability.
Common positive themes in Phoenix reviews: The free assessment with no consultation charge is frequently cited as a reason for initially trying the platform. The clarity of pricing (medication cost only, no hidden clinical fees) reduces billing-related friction that generates negative reviews for layered-fee competitors. Delivery speed and packaging discretion score well consistently. The text-based follow-up model is described as practical and responsive.
Common negative themes in Phoenix reviews: The men-only scope means roughly half the potential patient population cannot use the service - reviews from patients who signed up before realizing the gender restriction do appear in the dataset. Some reviews note that the text-only consultation model limits nuance for complex medical histories - patients wanting face-to-face clinical interaction are not well served. A subset of reviews reference medication availability issues during the 2024-2025 Ozempic supply shortages, though this is a market-wide issue rather than Phoenix-specific.
Pros and Cons
Strengths
- +Free assessment and free consultation - no upfront clinical fees
- +Highest Trustpilot rating in Canadian GLP-1 telehealth: 4.6/5 from 879 reviews
- +Four brand-name GLP-1 options (Ozempic, Wegovy, Mounjaro, Zepbound)
- +Ozempic from $299 with 20% discount - lowest brand-name list price widely advertised
- +Unlimited text-based follow-up at no extra charge
- +Free discreet delivery with 2-3 day shipping
- +Men-specific clinical protocols and support content
- +Quebec coverage - unavailable through Felix Health
- +No referral required; fully online from assessment to delivery
- +Sister platform (Raven) available for female partners or family members
Weaknesses
- -Men-only - not available for women (use Raven instead)
- -Does not serve PEI or Canadian territories
- -No generic semaglutide - cannot match Felix or MyRocky $149/month pricing
- -No direct insurance billing - patients must submit claims themselves
- -Text-only consultations - no video or phone option for complex cases
- -Brand-name medication pricing is higher than generic alternatives from other platforms
- -Phoenix Digital Health Inc. does not publish named clinical leadership publicly
Who Should NOT Use Phoenix
Medical Contraindications - Consult a Physician Before Starting
- !Women - Phoenix is men-only; women should use Raven or a gender-inclusive platform
- !Patients in PEI or the Northwest Territories, Nunavut, or Yukon - Phoenix does not operate in these regions
- !Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN2)
- !History of pancreatitis - GLP-1 therapy may increase recurrence risk
- !Severe gastrointestinal disease including gastroparesis
- !Current or planned pregnancy - GLP-1 medications are not approved for use during pregnancy
- !Type 1 diabetes - GLP-1 monotherapy is not appropriate as primary insulin replacement
- !Severe renal impairment (eGFR below 30) - requires specialist evaluation before GLP-1 initiation
- !Known hypersensitivity to semaglutide, tirzepatide, or formulation excipients
- !Patients under 18 years of age - GLP-1 weight management is not currently indicated for pediatric patients in Canada
This list is not exhaustive. Disclose your full medical history and medication list during the Phoenix assessment. The reviewing provider will screen for all relevant contraindications.
Phoenix vs Competitors
| Feature | Phoenix | Felix | MyRocky | Maple | Raven |
|---|---|---|---|---|---|
| Free assessment | Yes | No ($99) | No ($99) | No ($69-99) | Yes |
| Free follow-ups | Yes | Included | Included | No ($69-99) | Yes |
| Generic semaglutide | No | Yes (~$149) | Yes (~$149) | No | No |
| Ozempic (brand-name) | $299-375 | ~$220-250 | ~$220-250 | ~$220-250 | Varies |
| Mounjaro / Zepbound | Yes | Yes | Yes | Yes | Yes |
| Quebec coverage | Yes | No | Yes | Yes | Yes |
| PEI coverage | No | Yes | Yes | Yes | No |
| Direct insurance billing | No | No | No | No | No |
| Trustpilot rating | 4.6/5 | N/A | N/A | Varies | 4.5/5 |
| Gender restriction | Men only | All genders | All genders | All genders | Women only |
Verdict
Phoenix scores 8.2/10 in our independent assessment. That score reflects a platform with the strongest Trustpilot validation in the Canadian GLP-1 telehealth space, a genuinely free consultation model, four brand-name medication options, and men-specific clinical programming - but limited by a pricing floor that does not reach the generic semaglutide tier, no insurance billing capability, and a geographic footprint that excludes PEI and all territories.
Phoenix is the best choice for Canadian men who prioritize three things: a free-to-start assessment with no upfront clinical fees, brand-name medication selection including both tirzepatide options (Mounjaro and Zepbound), and the strongest independently verified patient review record in the category. For men in Quebec, Phoenix is particularly valuable given that Felix Health - the most widely recognized competitor - does not serve that province.
For cost-focused patients, Felix Health and MyRocky both offer generic semaglutide from $149/month with included clinical support - at roughly half the annual medication cost of Phoenix's brand-name pricing. The $99 upfront consultation at Felix or MyRocky is recouped within the first two months through medication savings for most patients. Phoenix's value is strongest for men who specifically want brand-name medications, a zero-fee consultation, or the men's-health-specific clinical framing.
Looking for lower-cost GLP-1 options with generic semaglutide?
Felix Health and MyRocky both offer generic semaglutide from $149/month with included clinical support across Canada.
Frequently Asked Questions
Is Phoenix available for women?
No. Phoenix is a men-only platform. Women seeking equivalent telehealth GLP-1 services through Phoenix Digital Health Inc. should visit Raven (raven.ca), which is the company's parallel platform for women and uses the same underlying clinical and technology infrastructure.
What does Phoenix cost per month?
The assessment and consultation are free. There are no ongoing clinical fees. You pay only for your medication. Ozempic is priced at $375/pen list price with a promotional 20% discount available bringing it to $299. Mounjaro, Wegovy, and Zepbound pricing varies by dose - contact Phoenix directly for current pricing on these medications. Delivery is free across all nine served provinces.
Does Phoenix serve Quebec?
Yes. Phoenix operates in nine provinces including Quebec - ON, BC, AB, MB, SK, QC, NS, NB, and NL. PEI is the only province not currently served. The three federal territories (Northwest Territories, Nunavut, Yukon) are also not served.
How does Phoenix compare to Felix Health?
The key differences: Phoenix is free to start (no consultation fee) while Felix charges $99 once upfront. Phoenix has a higher Trustpilot rating (4.6 vs no published rating for Felix). Felix offers generic semaglutide from ~$149/month while Phoenix offers brand-name only from $299. Felix serves all 9 standard provinces but not Quebec; Phoenix serves 9 provinces including Quebec but not PEI. For cost-sensitive patients, Felix (or MyRocky) is typically less expensive annually. For men who want a zero-fee entry and brand-name medication options, Phoenix is the stronger choice.
Does Phoenix accept insurance?
Phoenix does not offer direct insurance billing. Patients whose employer benefit plans cover GLP-1 medications will need to pay at the point of purchase and submit receipts to their benefits provider for reimbursement. Phoenix provides documentation to support insurance claims. If direct billing is important to your decision, DooU is currently the only Canadian GLP-1 telehealth platform offering this through select participating insurers.
What are Phoenix's Trustpilot reviews like?
Phoenix holds a 4.6/5 rating from 879 verified Trustpilot reviews as of June 2026 - the strongest independently verified patient satisfaction score among Canadian GLP-1 telehealth platforms with a substantial review volume. Common positive themes include the free consultation, medication delivery speed, and responsive text-based support. Common negative themes relate to the men-only restriction and the text-only consultation format for complex cases.
Can I use Phoenix without a referral from my doctor?
Yes. No referral from a family physician or specialist is required to begin the Phoenix assessment. The intake process is self-initiated entirely online. Phoenix's licensed providers conduct an independent clinical assessment based on your intake responses and make a prescribing decision directly. You do not need to involve your existing family doctor at any stage of the Phoenix process, though sharing your Phoenix treatment history with your primary care provider is advisable for continuity of care.
Sources
- 1. Phoenix.ca - Platform overview, pricing, and province coverage (accessed June 2026)
- 2. Phoenix Digital Health Inc. - Corporate registration and subsidiary disclosures
- 3. Raven.ca - Sister platform for women; Phoenix Digital Health Inc.
- 4. Trustpilot - Phoenix patient reviews (accessed June 2026)
- 5. Health Canada Drug Database - Ozempic, Wegovy, Mounjaro, Zepbound product monographs
- 6. NEJM - SCALE trial: semaglutide 2.4 mg for obesity, Wilding et al. 2021
- 7. NEJM - SURMOUNT-1 trial: tirzepatide for obesity, Jastreboff et al. 2022
- 8. Apotex Inc. - Generic semaglutide product launch announcement, May 2026
- 9. WeightLossInjections.ca editorial team - independent pricing survey, June 2026
- 10. CMAJ - Canadian clinical practice guidelines for obesity management (2020, updated 2023)